Clinical Trials Browser

Pancreatic Metastatic Cancer × Irinotecan × 30 days × Clear all

NCT02143219 2026-04-15

PAMELA70

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Pancreatic Metastatic Cancer